Detecting cancer cells isn’t always easy, especially when only a few tumor cells are mixed among many healthy ones. But Veridex, a Johnson & Johnson (JNJ) company, today announced a collaboration aimed at developing exactly such a blood test. With Massachusetts General Hospital and another J&J’s unit, Ortho Biotech Oncology Research & Development, Veridex will…